GeneDx Holdings (WGS) Other Non-Current Assets (2020 - 2026)
GeneDx Holdings' (WGS) quarterly Other Non-Current Assets came in at $4.3 million in Q2 2026, down 0.67% year-over-year from $4.3 million in Q2 2025, and little changed quarter-over-quarter from $4.3 million in Q1 2026.
Analysis
GeneDx Holdings (WGS) Other Non-Current Assets (2020 - 2026) Analysis & Trends
GeneDx Holdings (WGS) has reported Other Non-Current Assets for 7 consecutive years, with $4.3 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other Non-Current Assets fell 0.67% year-over-year to $4.3 million in Q2 2026; TTM through Jun 2026 was $4.3 million, a 0.67% decrease from a year earlier, with the FY2025 full-year figure at $4.3 million, changed 0.23% from the prior year.
- Other Non-Current Assets was $4.3 million for Q2 2026 at GeneDx Holdings, roughly flat from $4.3 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $14.4 million in Q2 2022 and troughed at $4.3 million in Q1 2025.
- A 5-year average of $6.4 million and a median of $4.4 million in 2024 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets soared 297.73% in 2022 and tumbled 66.42% in 2024, its largest moves.
- Over 5 years, Other Non-Current Assets stood at $7.4 million in 2022, then tumbled by 40.24% to $4.4 million in 2023, then declined by 2.42% to $4.3 million in 2024, then rose by 0.23% to $4.3 million in 2025, then dropped by 0.74% to $4.3 million in 2026.
- The last three Other Non-Current Assets figures came in at $4.3 million (Q2 2026), $4.3 million (Q1 2026), and $4.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | 49.99 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 277.00 Mn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 769.30 Mn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | 114.30 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 4.72 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | 56.73 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 40.63 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 5.56 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | 2.73 Mn |
| 10 | GeneDx Holdings | 3.01 Bn | 2.88 Bn | 78.24 Mn | 4.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.28 Mn |
| Mar 31, 2026 | 4.28 Mn |
| Dec 31, 2025 | 4.32 Mn |
| Sep 30, 2025 | 4.31 Mn |
| Jun 30, 2025 | 4.31 Mn |
| Mar 31, 2025 | 4.25 Mn |
| Dec 31, 2024 | 4.31 Mn |
| Sep 30, 2024 | 4.34 Mn |
| Jun 30, 2024 | 4.36 Mn |
| Mar 31, 2024 | 4.38 Mn |
| Dec 31, 2023 | 4.41 Mn |
| Sep 30, 2023 | 6.06 Mn |
| Jun 30, 2023 | 5.56 Mn |
| Mar 31, 2023 | 13.04 Mn |
| Dec 31, 2022 | 7.39 Mn |
| Sep 30, 2022 | 14.37 Mn |
| Jun 30, 2022 | 14.37 Mn |
| Mar 31, 2022 | 6.95 Mn |
| Dec 31, 2021 | 6.93 Mn |
| Sep 30, 2021 | 3.61 Mn |